Merck's Januvia gets approval for type 2 diabetes in US
Friday, October 20, 2006 10:00 IST Whitehouse Station, New Jersey
Merck & Co., Inc. announced that the US Food and Drug Administration (FDA) approved Januvia (sitagliptin phosphate), the first and only DPP-4 inhibitor available in the United States for the treatment of type 2 diabetes.
